Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
Loscalzo LM, Wasowski C, Paladini AC, Marder M (February 2008). „Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines”. Eur. J. Pharmacol.580 (3): 306–13. DOI:10.1016/j.ejphar.2007.11.011. PMID18048026.
Guzmán-Gutiérrez SL, Navarrete A (March 2009). „Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers”. Planta Med.75 (4): 295–301. DOI:10.1055/s-0029-1185306. PMID19219759.
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (April 2003). „Interaction between flavonoids and the blood-brain barrier: in vitro studies”. J. Neurochem.85 (1): 180–92. DOI:10.1046/j.1471-4159.2003.01652.x. PMID12641740.
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID21948594.edit
Hirata A, Murakami Y, Shoji M, Kadoma Y, Fujisawa S (2005). „Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression”. Anticancer Res.25 (5): 3367–74. PMID16101151.
Monforte MT, Trovato A, Kirjavainen S, Forestieri AM, Galati EM, Lo Curto RB (September 1995). „Biological effects of hesperidin, a Citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat”. Farmaco50 (9): 595–9. PMID7495469.
Ohtsuki K, Abe A, Mitsuzumi H, et al. (December 2003). „Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature”. J. Nutr. Sci. Vitaminol.49 (6): 447–50. PMID14974738.
Emim JA, Oliveira AB, Lapa AJ (February 1994). „Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice”. J. Pharm. Pharmacol.46 (2): 118–22. PMID8021799.
Galati EM, Monforte MT, Kirjavainen S, Forestieri AM, Trovato A, Tripodo MM (November 1994). „Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity”. Farmaco40 (11): 709–12. PMID7832973.
Loscalzo LM, Wasowski C, Paladini AC, Marder M (February 2008). „Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines”. Eur. J. Pharmacol.580 (3): 306–13. DOI:10.1016/j.ejphar.2007.11.011. PMID18048026.
Guzmán-Gutiérrez SL, Navarrete A (March 2009). „Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers”. Planta Med.75 (4): 295–301. DOI:10.1055/s-0029-1185306. PMID19219759.
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C (April 2003). „Interaction between flavonoids and the blood-brain barrier: in vitro studies”. J. Neurochem.85 (1): 180–92. DOI:10.1046/j.1471-4159.2003.01652.x. PMID12641740.
